Overcoming the Market Access Hurdle through Better Planning of Clinical Trials

PharmaPhorum recently published an article written by our Founder and CEO Yin Ho and Associate Director of Data and Analytics Rachel Jao, "Overcoming the Market Access Hurdle through Better Planning of Clinical Trials." The article points out that though regulatory approval is still a key step in getting a drug to market, it no longer guarantees market access. The authors discuss how clinical-trial design and the implications on reimbursement can help companies make better use of their resources and expedite the path to a successful drug launch.

Is there room for improvement in the planning and design of clinical trials... we believe the answer is yes!

Click here to read the full article.